The New York Times Company (NYT) Key Metrics
NYT valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $10.93B
- Enterprise value
- $9.95B
- P/E (TTM)
- 28.2 10-yr median 36.0
- Forward P/E
- 21.1
- PEG ratio
- 3.79
- Price / sales
- 3.7 10-yr median 3.2
- Price / book
- 5.2 10-yr median 4.5
- EV / EBITDA
- 16.8 10-yr median 18.2
- Dividend yield
- 1.35% $0.92 a year
- Beta
- 0.92
NYT key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNYT valuation Price multiples at each fiscal year-end price.
NYT returns How much profit the business earns on the capital it uses.
NYT per-share figures Results divided by the shares outstanding at year-end.
NYT financial health Debt, liquidity and how easily interest is covered.
NYT efficiency & capital use Working capital cycle and where the cash goes.
NYT valuation history
NYT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NYT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NYT cash returned to shareholders
NYT price vs earnings per share
NYT key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $11.45B | $8.63B | $8.12B | $5.43B | $8.14B | $8.70B | $5.39B | $3.72B | $3.04B | $2.17B |
| Enterprise value | $10.86B | $8.11B | $7.71B | $5.14B | $7.54B | $8.16B | $5.01B | $3.36B | $2.87B | $1.93B |
| P/E ratio | 33.3 | 29.4 | 34.9 | 31.2 | 37.0 | 86.9 | 38.5 | 29.6 | 707.4 | 74.5 |
| Price / sales | 4.1 | 3.3 | 3.3 | 2.4 | 3.9 | 4.9 | 3.0 | 2.1 | 1.8 | 1.4 |
| Price / book | 5.6 | 4.5 | 4.6 | 3.4 | 5.3 | 6.6 | 4.6 | 3.6 | 3.4 | 2.6 |
| Price / free cash flow | 20.8 | 22.6 | 24.0 | 47.7 | 34.7 | 33.0 | 37.3 | 46.7 | — | 33.8 |
| Price / operating cash flow | 19.6 | 21.0 | 22.5 | 36.0 | 30.2 | 29.2 | 28.4 | 23.7 | 35.0 | 23.0 |
| EV / sales | 3.8 | 3.1 | 3.2 | 2.2 | 3.6 | 4.6 | 2.8 | 1.9 | 1.7 | 1.2 |
| EV / EBITDA | 19.8 | 17.0 | 19.3 | 15.6 | 21.1 | 43.7 | 19.3 | 12.6 | 14.2 | 14.2 |
| EV / free cash flow | 19.7 | 21.3 | 22.8 | 45.2 | 32.2 | 31.0 | 34.7 | 42.2 | — | 30.1 |
| Earnings yield | 3.0% | 3.4% | 2.9% | 3.2% | 2.7% | 1.2% | 2.6% | 3.4% | 0.1% | 1.3% |
| Free cash flow yield | 4.8% | 4.4% | 4.2% | 2.1% | 2.9% | 3.0% | 2.7% | 2.1% | 0.1% | 3.0% |
| Dividend yield | 1.0% | 1.0% | 0.9% | 1.0% | 0.6% | 0.4% | 0.6% | 0.7% | 0.9% | 1.2% |
| Shareholder yield (dividends + buybacks) | 2.4% | 1.9% | 1.4% | 3.0% | 0.6% | 0.4% | 0.6% | 1.0% | 1.0% | 1.9% |
| Share price at fiscal year-end | $69.42 | $52.05 | $48.99 | $32.46 | $48.30 | $51.77 | $32.17 | $22.29 | $18.50 | $13.30 |
| Per share | ||||||||||
| Revenue per share | $17.13 | $15.60 | $14.65 | $13.81 | $12.31 | $10.61 | $10.82 | $10.47 | $10.20 | $9.55 |
| Earnings per share | $2.09 | $1.77 | $1.40 | $1.04 | $1.31 | $0.60 | $0.84 | $0.75 | $0.03 | $0.18 |
| Operating cash flow per share | $3.54 | $2.48 | $2.18 | $0.90 | $1.60 | $1.77 | $1.13 | $0.94 | $0.53 | $0.58 |
| Free cash flow per share | $3.34 | $2.30 | $2.04 | $0.68 | $1.39 | $1.57 | $0.86 | $0.48 | $0.01 | $0.39 |
| Cash per share | $3.89 | $3.41 | $2.73 | $2.08 | $3.92 | $3.54 | $2.58 | $3.67 | $2.99 | $3.38 |
| Book value per share | $12.38 | $11.62 | $10.64 | $9.56 | $9.13 | $7.89 | $7.00 | $6.23 | $5.46 | $5.19 |
| Tangible book value per share | $8.50 | $7.60 | $6.42 | $5.21 | $8.06 | $6.81 | $6.15 | $5.36 | $4.54 | $4.29 |
| Dividends per share | $0.67 | $0.50 | $0.42 | $0.34 | $0.27 | $0.23 | $0.19 | $0.16 | $0.16 | $0.16 |
| Capex per share | $0.21 | $0.18 | $0.14 | $0.22 | $0.21 | $0.21 | $0.27 | $0.46 | $0.52 | $0.18 |
| Debt per share | $0.30 | $0.29 | $0.26 | $0.35 | $0.38 | $0.31 | $0.33 | $1.52 | $1.98 | $1.93 |
| Shares outstanding | 164.9M | 165.8M | 165.7M | 167.1M | 168.5M | 168.0M | 167.5M | 166.9M | 164.3M | 162.8M |
| Change in shares outstanding | −0.5% | +0.1% | −0.9% | −0.8% | +0.3% | +0.3% | +0.4% | +1.6% | +0.9% | −2.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 17.3% | 15.9% | 13.8% | 11.1% | 15.4% | 8.0% | 12.7% | 13.0% | 0.5% | 3.5% |
| Return on invested capital (ROIC) | 24.1% | 19.5% | 16.0% | 13.2% | 23.5% | 19.5% | 20.2% | 19.5% | 13.2% | 15.4% |
| Return on assets (ROA) | 11.8% | 10.6% | 8.9% | 6.8% | 9.0% | 4.6% | 6.5% | 5.8% | 0.2% | 1.3% |
| Return on tangible assets | 14.6% | 13.5% | 11.5% | 9.6% | 9.2% | 4.7% | 7.2% | 6.1% | 0.2% | 1.4% |
| Free cash flow margin | 19.5% | 14.7% | 13.9% | 4.9% | 11.3% | 14.8% | 8.0% | 4.6% | 0.1% | 4.1% |
| Income quality (OCF / net income) | 1.70 | 1.40 | 1.55 | 0.87 | 1.22 | 2.98 | 1.36 | 1.25 | 20.18 | 3.24 |
| Financial health | ||||||||||
| Total debt | $48.7M | $47.8M | $42.9M | $59.1M | $63.6M | $52.7M | $55.1M | $253.6M | $325.3M | $313.7M |
| Cash & short-term investments | $642.2M | $565.9M | $451.6M | $347.4M | $661.0M | $595.2M | $432.2M | $612.8M | $491.5M | $550.2M |
| Net debt | −$593.4M | −$518.1M | −$408.7M | −$288.2M | −$597.4M | −$542.5M | −$377.1M | −$359.2M | −$166.2M | −$236.6M |
| Debt / equity | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | 0.05 | 0.24 | 0.36 | 0.37 |
| Debt / assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.12 | 0.15 | 0.14 |
| Net debt / EBITDA | −1.08 | −1.09 | −1.02 | −0.88 | −1.67 | −2.90 | −1.45 | −1.35 | −0.82 | −1.74 |
| Current ratio | 1.54 | 1.53 | 1.28 | 1.15 | 1.70 | 1.72 | 1.64 | 1.33 | 1.80 | 2.00 |
| Quick ratio | 1.54 | 1.53 | 1.28 | 1.05 | 1.64 | 1.66 | 1.57 | 1.29 | 1.75 | 1.96 |
| Interest coverage | 386.2 | 345.2 | 272.5 | 252.5 | 348.5 | 242.4 | 46.0 | 6.1 | 5.9 | 2.6 |
| Working capital | $361.4M | $322.8M | $170.1M | $84.5M | $393.6M | $349.1M | $279.1M | $220.6M | $334.0M | $397.4M |
| Invested capital | $1.45B | $1.41B | $1.35B | $1.31B | $941.3M | $783.1M | $794.9M | $681.6M | $731.1M | $607.7M |
| Tangible asset value | $1.40B | $1.26B | $1.06B | $873.6M | $1.36B | $1.15B | $1.03B | $896.2M | $745.6M | $699.1M |
| Net current asset value | $72.3M | $22.1M | −$169.7M | −$278.1M | −$70.7M | −$143.7M | −$198.4M | −$260.5M | −$452.7M | −$545.0M |
| Graham number | $24.10 | $21.53 | $18.33 | $14.96 | $16.37 | $10.28 | $11.47 | $10.28 | $1.79 | $4.56 |
| Graham net-net per share | −$0.58 | −$0.97 | −$1.92 | −$2.37 | −$1.01 | −$1.38 | −$1.84 | −$2.17 | −$3.41 | −$3.90 |
| Capital allocation | ||||||||||
| Dividends paid | $110.4M | $82.9M | $69.5M | $56.8M | $45.3M | $38.4M | $31.6M | $26.4M | $26.0M | $25.9M |
| Share buybacks (net) | $165.3M | $85.0M | $44.6M | $105.1M | $0 | $0 | $0 | $10.5M | $4.1M | $15.7M |
| Dividend payout ratio | 32.1% | 28.2% | 29.9% | 32.7% | 20.6% | 38.4% | 22.6% | 21.0% | 605.3% | 89.1% |
| Dividends + buybacks / free cash flow | 50.1% | 44.0% | 33.7% | 142.3% | 19.3% | 14.6% | 21.9% | 46.4% | — | 64.8% |
| Capex / revenue | 1.2% | 1.1% | 0.9% | 1.6% | 1.7% | 1.9% | 2.5% | 4.4% | 5.1% | 1.9% |
| Capex / operating cash flow | 5.8% | 7.1% | 6.3% | 24.5% | 12.9% | 11.6% | 23.9% | 49.3% | 97.7% | 31.9% |
| Capex / depreciation | 0.36 | 0.32 | 0.24 | 0.40 | 0.52 | 0.49 | 0.67 | 1.31 | 1.37 | 0.49 |
| Stock-based compensation / revenue | 2.6% | 2.6% | 2.3% | 1.5% | 1.1% | 0.8% | 0.7% | 0.7% | 0.9% | 0.8% |
| R&D / revenue | 9.4% | 9.6% | 9.4% | 8.8% | 7.8% | 7.4% | 5.9% | 4.8% | — | — |
| SG&A / revenue | 22.5% | 22.7% | 23.5% | 24.1% | 26.3% | 25.4% | 18.6% | 27.0% | 52.3% | 45.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 34.9 | 34.7 | 34.6 | 35.6 | 36.6 | 40.6 | 43.9 | 42.5 | 41.6 | 47.5 |
| Days of inventory on hand | — | — | — | 13.3 | 11.0 | 11.1 | 10.1 | 9.3 | 11.5 | 10.3 |
| Days payables outstanding | 34.0 | 33.5 | 33.8 | 36.5 | 43.9 | 45.6 | 42.1 | 45.6 | 68.1 | 58.2 |
| Cash conversion cycle (days) | 0.9 | 1.2 | 0.8 | 12.4 | 3.7 | 6.2 | 11.8 | 6.2 | -15.0 | -0.4 |
| Receivables turnover | 10.46 | 10.51 | 10.55 | 10.25 | 9.96 | 8.98 | 8.32 | 8.59 | 8.77 | 7.69 |
| Payables turnover | 10.72 | 10.89 | 10.79 | 10.00 | 8.31 | 8.00 | 8.66 | 8.00 | 5.36 | 6.28 |
| Inventory turnover | — | — | — | 27.46 | 33.17 | 32.75 | 36.30 | 39.33 | 31.77 | 35.58 |
| Asset turnover | 0.97 | 0.93 | 0.92 | 0.91 | 0.85 | 0.81 | 0.85 | 0.81 | 0.78 | 0.68 |
| Average receivables | $270.2M | $246.0M | $230.0M | $225.2M | $208.3M | $198.5M | $217.9M | $203.7M | $191.1M | $202.3M |
| Average payables | $129.6M | $120.3M | $115.8M | $120.9M | $125.1M | $119.9M | $114.1M | $118.5M | $115.0M | $100.3M |
| Average inventory | — | — | — | $44.0M | $31.3M | $29.3M | $27.2M | $24.1M | $19.4M | $17.7M |
| Intangibles / total assets | 21.3% | 23.5% | 25.8% | 28.7% | 7.0% | 7.8% | 6.8% | 6.7% | 7.2% | 6.6% |
Computed from NYT's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NYT valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), New York Times traded at 33.3 times earnings, against a 10-year median of 36.0. Based on the latest twelve months, the trailing P/E is 28.2 and the forward P/E is 21.1. New York Times earned a return on equity of 17.3% and a return on invested capital of 24.1% in fiscal 2025. It ended the year with $48.7 million of debt and $642.2 million in cash and short-term investments, a net cash position of $593.4 million. It returned $275.7 million to shareholders: $110.4 million in dividends and $165.3 million in share buybacks, 50% of free cash flow.
See the NYT income statement, the NYT chart for price history, or the NYT stock overview for the latest quote and news.
NYT key metrics FAQ
What is New York Times's P/E ratio?
New York Times's trailing P/E ratio is 28.2 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 21.1. At the end of fiscal 2025 it was 33.3, compared with a 10-year median of 36.0.
What is New York Times's EV/EBITDA?
New York Times's enterprise value was 19.8 times EBITDA at the end of fiscal 2025 (enterprise value $10.9 billion, EBITDA $547.6 million); the current EV/EBITDA is 16.8.
What is New York Times's return on equity?
New York Times's return on equity (ROE) was 17.3% in fiscal 2025: net income of $344.0 million on average shareholders' equity of $2.0 billion.
What is New York Times's ROIC?
New York Times's return on invested capital was 24.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does New York Times have?
New York Times had total debt of $48.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.02 and more cash than debt.
What is New York Times's dividend yield?
New York Times's forward dividend yield is 1.35%. New York Times paid $110.4 million in dividends in fiscal 2025 ($0.67 per share), a payout ratio of 32.1%.
Does New York Times buy back its shares?
Yes. New York Times spent $165.3 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.5% over the year, to 164.9M..
What is New York Times's free cash flow yield?
New York Times generated $550.5 million of free cash flow in fiscal 2025, a free cash flow yield of 4.8% on its market value at year-end ($11.5 billion).
What is New York Times's current ratio?
New York Times's current ratio was 1.54 at the end of fiscal 2025: current assets were 1.54 times current liabilities.